title: ES Cell International & regenerative medicine.
abstract: ES Cell International believes that human embryonic stem cells offer a renewable source material for the elaboration of a multitude of different tissues for use in human cell replacement therapy. There are many challenges to the successful implementation of this vision including technical, regulatory, financial and ethical hurdles. However with demographic changes towards an aging population in the richer countries, leading to growing demands of ways to combat degenerative disease, science would be remiss not to explore every potential medical solution.
authors.affiliation: ES Cell International, Helios, Singapore. acolman@escellinternational.com
authors.forename: Alan
authors.initials: A
authors.lastname: Colman
authors.forename: Doug
authors.initials: D
authors.lastname: Alliston
mesh_terms: D017690:Cell Transplantation / Q000639:trends; D004345:Drug Industry; D053595:Embryonic Stem Cells; D006801:Humans; D038622:Internationality; D044968:Regenerative Medicine; D012846:Singapore